Want to create an interactive transcript for this episode?
Podcast: CME
Episode: The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
Description:
Host: Pablo Garcia-Pavia, MD, PhD
Guest: Francesco Cappelli, MD
Achieving optimal outcomes in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) remains a challenge as diagnosis is often delayed. Patients have a reduced life expectancy and experience debilitating pain and poor quality of life. Hear from the experts as they review the latest information on new and emerging treatment options for transthyretin amyloidosis and how this condition affects patients with cardiomyopathy.